EKIP– Expert Club for Economics and Politics A Different Opinion
On 05.07.2018, EMA – the European Medicines Agency, issued a statement on the so-called “precautionary recall” of valsartan-containing products due to a received signal for a detected adulteration in the raw substance, namely NDMA – N-nitrosodimethylamine. The signal was submitted by the manufacturing company, namely the China-based “Zhejiang Huahai …
More »Valsartan - truths versus myths and what does this mean for patients?
